Jane Renshaw

989 total citations
19 papers, 668 citations indexed

About

Jane Renshaw is a scholar working on Molecular Biology, Neurology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Jane Renshaw has authored 19 papers receiving a total of 668 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 4 papers in Neurology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jane Renshaw's work include Renal and related cancers (9 papers), Cancer therapeutics and mechanisms (4 papers) and Neuroblastoma Research and Treatments (4 papers). Jane Renshaw is often cited by papers focused on Renal and related cancers (9 papers), Cancer therapeutics and mechanisms (4 papers) and Neuroblastoma Research and Treatments (4 papers). Jane Renshaw collaborates with scholars based in United Kingdom, Switzerland and Germany. Jane Renshaw's co-authors include Kathy Pritchard‐Jones, Linda King‐Underwood, Michael R. Stratton, Nazneen Rahman, CR Pinkerton, Jerry Pelletier, Sylvain Baruchel, Laura Arbour, Steven A. Narod and Patricia N. Tonin and has published in prestigious journals such as Nature Genetics, Journal of Clinical Oncology and Blood.

In The Last Decade

Jane Renshaw

18 papers receiving 652 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jane Renshaw United Kingdom	12	528	149	121	102	100	19	668
Ángela Gutiérrez-Camino Spain	16	338 0.6×	52 0.3×	162 1.3×	187 1.8×	124 1.2×	37	667
Maoxiang Qian China	11	315 0.6×	77 0.5×	118 1.0×	39 0.4×	189 1.9×	43	516
Shivakumar Subramaniyam United States	10	350 0.7×	47 0.3×	177 1.5×	29 0.3×	45 0.5×	21	624
O. I. Olopade United States	9	209 0.4×	52 0.3×	195 1.6×	21 0.2×	44 0.4×	14	491
Eivind Smeland Norway	14	98 0.2×	195 1.3×	231 1.9×	23 0.2×	27 0.3×	22	441
Henderson Es United States	15	157 0.3×	47 0.3×	227 1.9×	46 0.5×	293 2.9×	29	693
Colvin Om United States	9	169 0.3×	52 0.3×	84 0.7×	14 0.1×	190 1.9×	11	428
Hai‐Rong Qiu China	13	171 0.3×	36 0.2×	150 1.2×	24 0.2×	216 2.2×	60	498
Tanja A. Grüber United States	18	306 0.6×	50 0.3×	260 2.1×	296 2.9×	552 5.5×	51	1.1k
Manali Rupji United States	13	186 0.4×	111 0.7×	165 1.4×	16 0.2×	59 0.6×	45	479

Countries citing papers authored by Jane Renshaw

Since Specialization

Citations

This map shows the geographic impact of Jane Renshaw's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jane Renshaw with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jane Renshaw more than expected).

Fields of papers citing papers by Jane Renshaw

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jane Renshaw. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jane Renshaw. The network helps show where Jane Renshaw may publish in the future.

Co-authorship network of co-authors of Jane Renshaw

This figure shows the co-authorship network connecting the top 25 collaborators of Jane Renshaw. A scholar is included among the top collaborators of Jane Renshaw based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jane Renshaw. Jane Renshaw is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

1.

Selfe, Joanna, Alan McIntyre, Kathryn R. Taylor, et al.. (2017). IGF1R signalling in testicular germ cell tumour cells impacts on cell survival and acquired cisplatin resistance. The Journal of Pathology. 244(2). 242–253. 25 indexed citations

2.

Clarke, Paul A., Karen Barker, Yvan H. Chanthery, et al.. (2016). Inhibition of mTOR-kinase destabilizes MYCN and is a potential therapy for MYCN-dependent tumors. Oncotarget. 7(36). 57525–57544. 40 indexed citations

3.

Harrap, Kenneth R. & Jane Renshaw. (2015). Intracellular Nucleotide Pools and Their Significance in Antimetabolite Therapy1. Antibiotics and chemotherapy/Antibiotica et chemotherapia. 28. 68–77.

4.

Renshaw, Jane, Kathryn R. Taylor, Ryan T. Bishop, et al.. (2013). Dual Blockade of the PI3K/AKT/mTOR (AZD8055) and RAS/MEK/ERK (AZD6244) Pathways Synergistically Inhibits Rhabdomyosarcoma Cell Growth In Vitro and In Vivo. Clinical Cancer Research. 19(21). 5940–5951. 110 indexed citations

5.

Renshaw, Jane, et al.. (2007). A phase I two arm trial of AS703569 (R763), an orally available aurora kinase inhibitor, in subjects with solid tumors: preliminary results. Journal of Clinical Oncology. 25(18_suppl). 14130–14130. 23 indexed citations

6.

Renshaw, Jane, Rosanne M. Orr, Michael I. Walton, et al.. (2004). Disruption of WT1 gene expression and exon 5 splicing following cytotoxic drug treatment: Antisense down-regulation of exon 5 alters target gene expression and inhibits cell survival. Molecular Cancer Therapeutics. 3(11). 1467–1484. 25 indexed citations

7.

Renshaw, Jane, Rosanne M. Orr, Michael I. Walton, et al.. (2004). Disruption of WT1 gene expression and exon 5 splicing following cytotoxic drug treatment: antisense down-regulation of exon 5 alters target gene expression and inhibits cell survival.. PubMed. 3(11). 1467–84. 29 indexed citations

8.

Yanagisawa, T., Anne B. Newman, Helen M. Coley, et al.. (1999). BIRICODAR (VX-710; Incel™): an effective chemosensitizer in neuroblastoma. British Journal of Cancer. 80(8). 1190–1196. 45 indexed citations

9.

Yanagisawa, T., Anne B. Newman, Helen M. Coley, et al.. (1999). BIRICODAR (VX-710; Incel™): an effective chemosensitizer in neuroblastoma. British Journal of Cancer. 80(8). 1190–1196. 5 indexed citations

10.

Cowie, Fiona, Kathy Pritchard‐Jones, Jane Renshaw, & CR Pinkerton. (1998). Multidrug resistance modulation in rhabdomyosarcoma and neuroblastoma cell lines.. International Journal of Oncology. 12(5). 1143–9. 9 indexed citations

11.

Renshaw, Jane, Linda King‐Underwood, & Kathy Pritchard‐Jones. (1997). Differential splicing of exon 5 of the Wilms tumour (WT1) gene. Genes Chromosomes and Cancer. 19(4). 256–266. 34 indexed citations

12.

Renshaw, Jane, Linda King‐Underwood, & Kathy Pritchard‐Jones. (1997). Differential splicing of exon 5 of the Wilms tumour (WT1) gene. Genes Chromosomes and Cancer. 19(4). 256–266. 1 indexed citations

13.

Anderson, John, Jane Renshaw, Aidan McManus, et al.. (1997). Amplification of the t(2; 13) and t(1; 13) translocations of alveolar rhabdomyosarcoma in small formalin-fixed biopsies using a modified reverse transcriptase polymerase chain reaction.. PubMed. 150(2). 477–82. 34 indexed citations

14.

King‐Underwood, Linda, Jane Renshaw, & Kathy Pritchard‐Jones. (1996). Mutations in the Wilms' tumor gene WT1 in leukemias. Blood. 87(6). 2171–2179. 134 indexed citations

15.

Rahman, Nazneen, Laura Arbour, Patricia N. Tonin, et al.. (1996). Evidence for a familial Wilms' tumour gene (FWT1) on chromosome 17q12–q21. Nature Genetics. 13(4). 461–463. 99 indexed citations

16.

Rainov, Nikolai G., et al.. (1995). Association of Wilmsʼ Tumor with Primary Brain Tumor in Siblings. Journal of Neuropathology & Experimental Neurology. 54(2). 214–223. 4 indexed citations

17.

Pritchard‐Jones, Kathy, Jane Renshaw, & Linda King‐Underwood. (1994). The Wilms tumour (WT1) gene is mutated in a secondary leukaemia in a WAGR patient. Human Molecular Genetics. 3(9). 1633–1637. 46 indexed citations

18.

Renshaw, Jane & Kenneth R. Harrap. (1986). In Vivo Inhibition of Mouse Liver Methyltransferase Enzymes Following Treatment with 2′-Deoxycoformycin and 2′-Deoxyadenosine. Advances in experimental medicine and biology. 195 Pt B. 673–675. 3 indexed citations

19.

Renshaw, Jane, et al.. (1984). Purine Deoxyribonucleoside Induced Hepatotoxicity in the Mouse. Advances in experimental medicine and biology. 165 Pt B. 363–366. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact